NA
PCYC

Navellier & Associates’s PHARMACYCLICS INC PCYC Stock Holding History

Navellier & Associates’s Portfolio PCYC Stock Details PCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-2,749
Closed -$276K – 374
2014
Q1 		$276K Sell
2,749
-1,739
-39% -$226K 0.01% 267
2013
Q4 		$475K Buy
4,488
+42
+0.9% +$5.1K 0.02% 186
2013
Q3 		$615K Sell
4,446
-4
-0.1% -$444 0.02% 157
2013
Q2 		$354K Buy
+4,450
New +$364K 0.02% 179

Other funds holding PCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Navellier & Associates's PCYC Position: Q2 2014 in Review

Navellier & Associates sold out of PHARMACYCLICS INC (PCYC) in Q2 2014, closing a stake of 2,749 shares — an estimated $276K sold.

Navellier & Associates first reported a position in PCYC in Q2 2013 and held it in 4 quarters. The position peaked at $615K in Q3 2013. 251 funds tracked by Wall St. Rank hold PCYC as of Q2 2014.

  • Navellier & Associates reported no remaining PHARMACYCLICS INC position as of Q2 2014 after selling out during the quarter.
  • Navellier & Associates sold 2,749 PHARMACYCLICS INC shares in Q2 2014, an estimated $276K.
  • Navellier & Associates first reported a position in PHARMACYCLICS INC in Q2 2013 and held it in 4 quarters.
  • Navellier & Associates's PHARMACYCLICS INC position peaked at $615K in Q3 2013.
  • 251 funds tracked by Wall St. Rank held PHARMACYCLICS INC as of Q2 2014.

Based on Navellier & Associates's 13F filing for Q2 2014, filed 9 Jul 2014.